Featured Research

from universities, journals, and other organizations

H Pylori Screening May Reduce Gastric Cancer Risk

Date:
February 16, 1999
Source:
University Of Michigan
Summary:
Researchers at the University of Michigan have completed a study that provides compelling clinical and economic evidence for population-based Helicobactor pylori (H pylori) screening to reduce the risk of gastric cancer.

ANN ARBOR---Researchers at the University of Michigan have completed a study that provides compelling clinical and economic evidence for population-based Helicobactor pylori (H pylori) screening to reduce the risk of gastric cancer.

Investigators, employing a comprehensive computer analysis, found that H pylori screening could potentially provide important health benefits at a reasonable cost even if elimination of H pylori reduced the increased risk of gastric cancer by only 15 percent in infected individuals.

The study is published in Archives of Internal Medicine.

H pylori's role in most peptic ulcer disease cases has been well documented. People infected with H pylori are also at an increased risk for gastric cancer, prompting the World Health Organization to classify H pylori as a group 1 carcinogen in humans. However, to date, no clinical trial has demonstrated whether the elimination of H pylori infection actually decreases an infected person's already-increased risk for this relatively rare, but frequently lethal, cancer.

"A clinical trial providing definitive evidence that elimination of H pylori infection reduces gastric cancer risk will not be completed for several years," says A. Mark Fendrick, M.D., associate professor of internal medicine in the U-M Health System. "In the interim, we constructed a computer simulation to estimate the potential health and economic consequences of H pylori screening over a range of cancer risk-reduction.

"The ease and low cost of H pylori diagnosis and treatment should make screening attractive to both patients and health care providers. Interestingly, if elimination of H pylori infection reduces cancer risk significantly, this cancer prevention program has the potential to be more cost-effective than mammography and PSA testing."

This is largely due to two factors. First, gastric cancer strikes earlier in life than other common cancers. Therefore, each gastric cancer case prevented led to a significant number of life-years saved. Second, a person only has to be screened for H pylori once in their lifetime since H pylori infection is usually acquired in childhood and re-infection is extremely rare in adults.

The computer model determined that one-time H pylori screening was cost-effective when H pylori eradication reduced the risk of gastric cancer in infected individuals by as little as 15 percent. The analytical model also estimated that H pylori treatment guided by a simple blood test provided a relatively low cost per life-year saved. If elimination of H pylori lowered the risk of gastric cancer to a level similar to individuals who were never infected, just over $6,000 would need to be spent on screening to save an additional year of life---a dollar amount far lower than many commonly accepted medical interventions.

"We set out to estimate the level of cancer risk-reduction necessary to make it worthwhile to recommend H pylori screening to individuals at low risk of gastric cancer on both clinical and economical grounds," Fendrick says. "Since many Americans have a great fear of cancer, we believed they would undergo a simple blood test and take medications for two weeks to reduce the risk of a rare but highly fatal cancer, even if the definitive evidence was not in."

Fendrick says a parallel could be drawn to prostate-specific antigen testing (PSA) to detect prostate cancer. "Even though there remains uncertainty whether detecting early prostate cancers saves lives, Americans have adopted this strategy with unbridled enthusiasm. This decision is based not entirely on the scientific evidence. I would venture to say that the adoption of this or any unproven cancer screening program is driven by our cancer phobia."

H Pylori is usually treated with a two-week regimen consisting of a combination of two antibiotics and a medication that decreases acid product in the stomach. This treatment plan is successful more than 90 percent of the time in permanently eliminating H pylori infection.

"Population based screening of asymptomatic individuals has the potential to produce real important health benefits in terms of reducing gastric cancer," Fendrick says, "because each gastric cancer case prevented led to a significant number of life-years saved."

The study was conducted by researchers in the Consortium for Health Outcomes, Innovation and Cost-Effectiveness Studies (CHOICES)---a research unit funded jointly by the Departments of Medicine and Surgery devoted to the Multidisciplinary study of the quality and economic impact of health care services.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "H Pylori Screening May Reduce Gastric Cancer Risk." ScienceDaily. ScienceDaily, 16 February 1999. <www.sciencedaily.com/releases/1999/02/990212101121.htm>.
University Of Michigan. (1999, February 16). H Pylori Screening May Reduce Gastric Cancer Risk. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1999/02/990212101121.htm
University Of Michigan. "H Pylori Screening May Reduce Gastric Cancer Risk." ScienceDaily. www.sciencedaily.com/releases/1999/02/990212101121.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins